38 related articles for article (PubMed ID: 194659)
21. Discrimination between nicotinic receptors in vertebrate ganglia and skeletal muscle by alpha-bungarotoxin and cobra venoms.
Bursztajn S; Gershon MD
J Physiol; 1977 Jul; 269(1):17-31. PubMed ID: 894538
[TBL] [Abstract][Full Text] [Related]
22. Occupancy of the cholinergic receptors in relation to changes in the endplate potential.
Albuquerque EX; Barnard EA; Jansson SE; Wieckowski J
Life Sci; 1973 Jun; 12(12):545-52. PubMed ID: 4752481
[No Abstract] [Full Text] [Related]
23. Amphetamine inhibition of alpha-bungarotoxin binding at the mouse neuromuscular junction.
Skau KA; Gerald MC
Life Sci; 1977 May; 20(9):1495-9. PubMed ID: 195174
[No Abstract] [Full Text] [Related]
24. Use of bungarotoxins for the study of bioregulation of acetylcholine receptors [proceedings].
Chang CC
Toxicon; 1976; 14(6):407-8. PubMed ID: 189459
[No Abstract] [Full Text] [Related]
25. Nicotinic transmission in sympathetic ganglia: blockade by the snake venom neurotoxin kappa-bungarotoxin.
Chiappinelli VA; Dryer SE
Neurosci Lett; 1984 Sep; 50(1-3):239-44. PubMed ID: 6093012
[TBL] [Abstract][Full Text] [Related]
26. Department of Pharmacology, The School of Pharmacy, University of London, London, Great Britain.
Brown DA; Fumagalli L
Brain Res; 1977 Jun; 129(1):165-8. PubMed ID: 194659
[No Abstract] [Full Text] [Related]
27. Antibiotic blockade of neuromuscular function.
Pittinger C; Adamson R
Annu Rev Pharmacol; 1972; 12():169-84. PubMed ID: 4261048
[No Abstract] [Full Text] [Related]
28. On the pharmacology of autonomic ganglia.
Willems JL
Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:244+. PubMed ID: 4404132
[No Abstract] [Full Text] [Related]
29. Neuronal nicotinic receptor subtypes.
Lindstrom J; Anand R; Peng X; Gerzanich V; Wang F; Li Y
Ann N Y Acad Sci; 1995 May; 757():100-16. PubMed ID: 7611667
[No Abstract] [Full Text] [Related]
30. Drug interactions in antiarrhythmic therapy.
Bigger JT; Giardina EG
Ann N Y Acad Sci; 1984; 427():140-62. PubMed ID: 6331249
[No Abstract] [Full Text] [Related]
31. Drug interactions at (pharmacodynamically active) receptor sites.
Schou JS
Pharmacol Ther; 1982; 17(2):199-210. PubMed ID: 6294692
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
